Avantium signs FDCA capacity reservation agreement with Will & Co
Announced on 12 November 2026, this reservation covers FDCA (furandicarboxylic acid) that will be produced in plants operated by licensees of Avantium's YXY technology. It extends the collaboration launched in February 2026 between the two companies in the coatings, adhesives, sealants and elastomers (CASE) markets.
Volumes intended for paints, adhesives and construction materials
Will & Co, a distributor of specialty chemicals, including bio-based products, has signed with Avantium a FDCA capacity reservation agreement. According to the press release, this agreement reflects the distributor's interest in future access to this molecule for applications in the CASE markets.
FDCA is a bio-based building block that can be used in alkyd resins, surfactants and polyester polyols. Its potential applications range from paints and adhesives to flooring, roofing, pipes, automotive components and construction materials.
Jacques van Lindonk, Chief Executive Officer of Will & Co, stated: “This capacity reservation reflects our confidence in the potential of FDCA in the CASE markets. [...] Reserving future capacity is a logical next step, as we work to offer FDCA-based solutions to our customers and the broader market.”
A reservation subject to a final agreement with each licensee
Under the agreement, Will & Co has expressed its interest in reserving future FDCA capacity in plants operated by licensees of YXY technology. Avantium intends to introduce the distributor to potential licensees and facilitate discussions on securing these capacities.
These discussions remain subject to a definitive agreement between Will & Co and the relevant licensee. In parallel, the two companies are continuing their work on developing applications for the CASE market, with Avantium providing FDCA, its technical expertise and other forms of support.
Demand secured in advance to support licensees' investment
The transaction is part of Avantium's licensing model. For potential licensees, these reservations provide greater visibility into the demand likely to absorb the output of future FDCA plants.
By building commercial demand ahead of new capacity, the group aims to reduce the industrial project risk for these licensees and thereby support investment in future FDCA production.
Marco Jansen, Commercial Director of Avantium, stressed that this reservation “demonstrates tangible market interest in FDCA for CASE applications, while supporting our strategy of licensing our YXY technology to partners worldwide”.
The announcement comes the day after the closing, on 11 November 2026, of a €55.45 million rights issue, launched in particular to finance the ramp-up of Avantium's flagship FDCA plant in Delfzijl. The reservation signed with Will & Co, by contrast, concerns future capacity operated under license.
